Professional Documents
Culture Documents
- r
PROCJENA ENDOTELNE FUNKCIJE
PROCJENA ENDOTELNE FUNKCIJE
1. direktno mjerenje NO
1. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293-304
2. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.Thromb Haemost.2006;95:49-55.
PROCJENA ENDOTELNE FUNKCIJE
1. direktno mjerenje NO
2. posredno mjerenje NO
1. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293-304
2. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.Thromb Haemost.2006;95:49-55.
PROCJENA ENDOTELNE FUNKCIJE
1. direktno mjerenje NO
2. posredno mjerenje NO
1. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293-304
2. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.Thromb Haemost.2006;95:49-55.
PROCJENA ENDOTELNE FUNKCIJE
1. direktno mjerenje NO
2. posredno mjerenje NO
1. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293-304
2. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.Thromb Haemost.2006;95:49-55.
PROCJENA VAZOMOTORNE FUNKCIJE ENDOTELA (1)
- Celermajer 1992.*
- brahijalna, radijalna, femoralna arterija
- dvokomponentni test:
1. reaktivna hiperemija (FMD)
→ vazodilatacija kao mjera oslobađanja endotelnog NO
→ obrnuto proporcionalan stupnju ED
2. aplikacija ntg (NMD engl. nitroglicerin mediated dilatation)
→ maksimalni vazodilatacijski kapacitet
1. Celermajer DS, Sorensen KE, Gooch VM. Non-invasive detection of endothelial dysfunction in children and adults at risk of
atherosclerosis. Lancet. 1992;340:1111-5.*
2. Raitakari OT, Celermajer DS. Flow-mediated dilatation. J Clin Pharmacol. 2000;50,397-404.
3. Mirat J. Endotelna funkcija u kliničkoj praksi. Liječ Vjesn. 2005;127:82-85.
PROCJENA VAZOMOTORNE FUNKCIJE ENDOTELA (1)
- Celermajer 1992.*
- brahijalna, radijalna, femoralna arterija
- neinvazivnost, reproducibilnost
- visoki tehnički, vremenski i edukacijski zahtjevi
1. Celermajer DS, Sorensen KE, Gooch VM. Non-invasive detection of endothelial dysfunction in children and adults at risk of
atherosclerosis. Lancet. 1992;340:1111-5.*
2. Raitakari OT, Celermajer DS. Flow-mediated dilatation. J Clin Pharmacol. 2000;50,397-404.
3. Mirat J. Endotelna funkcija u kliničkoj praksi. Liječ Vjesn. 2005;127:82-85.
PROCJENA VAZOMOTORNE FUNKCIJE ENDOTELA (2)
FMD
FMD-test
a
TUNIKA
ADVENTICIJ
A
INTIM
A
MIOINTIMAL
LUM NE
EN STRUKTURE
PROCJENA VAZOMOTORNE FUNKCIJE ENDOTELA (4)
FMD-test
- nadlaktična kompresija na + 50 mmHg / 5 min
- reaktivna hiperemija
- hiperemijski protok unutar 30 s
- dilatacija - 2 minute
- očekivan porast 2r ≥ 6 %
NMD-test
- ≥ 10 min nakon FMD
- gliceriltrinitrat 400 μg s.l.
- promjena - protoka
- promjera (3. i 4. minuta)
1. Mirat J. Endotelna funkcija u kliničkoj praksi. Liječ Vjesn. 2005;127:82-85.
2. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA. i sur. International Brachial Artery
Reactivity Task Force Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the
brachial artery. J Am Coll Cardiol. 2002;39:257-65.
3.
PROCJENA VAZOMOTORNE FUNKCIJE ENDOTELA (5)
FMD-test
FMD – indeks
5,47 – 5,1 = 0,37
0,37 / 5,1 = 7,25 %
PLAZMATSKI ENDOTELNI BILJEZI (1)
1. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years.Thromb Haemost.2006;95:49-55.
2. Ružić A.i sur. Endotelna disfunkcija u "enigmatskoj slagalici" kardiovaskularnih bolesti. Med glas. 2009; 6(1): 2-15.
PLAZMATSKI ENDOTELNI BILJEZI (2)
Norma E
lno D
175 (%NP)
50 (%NP)
1. Ružić A, Peršić V, Miletić B, Obad A, Ružić T, Jovanović Ž, Pehar-Pejčinović V. Excercise-stimulated vWF release - a new tool
for routine assesment of endothelial function. Eur Heart J. 2008; Suppl 28: S492.
2. Balen S, Ružić A, Mirat J, Peršić V. Exercise induced von Wilebrand Factor release - New model for routine endothelial testing.
Med Hypotheses. 2007; 69: 1320-2.
PLAZMATSKI ENDOTELNI BILJEZI (3)
1. Ružić A, Peršić V, Miletić B, Obad A, Ružić T, Jovanović Ž, Pehar-Pejčinović V. Excercise-stimulated vWF release - a new tool
for routine assesment of endothelial function. Eur Heart J. 2008; Suppl 28: S492.
2. Balen S, Ružić A, Mirat J, Peršić V. Exercise induced von Wilebrand Factor release - New model for routine endothelial testing.
Med Hypotheses. 2007; 69: 1320-2.
PLAZMATSKI ENDOTELNI BILJEZI (4)
Raghunath PN, Timaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator system in human
coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1995:15:1432-43.
TERAPIJSKI PRISTUP DISFUNKCIJI ENDOTELA
1. Charo S. et al. Endothelial dysfunction and coronary risk reduction. J Cardiopulm Rehabil. 1998;18:60-7
2. Ružić A.i sur. Endotelna disfunkcija u "enigmatskoj slagalici" kardiovaskularnih bolesti. Med glas. 2009; 6(1): 2-15.
ED - PERSPEKTIVE RAZVOJA (1)
1. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293-304.
2. Lerman A, Zeiher AM. Endothelial Function: Cardiac Events. Circulation. 2005;111:363-8.
3. Ružić A.i sur. Endotelna disfunkcija u "enigmatskoj slagalici" kardiovaskularnih bolesti. Med glas. 2009; 6(1): 2-15.
ED - PERSPEKTIVE RAZVOJA (2)
1. Raitakari OT, Celermajer DS. Testing for endothelial dysfunction. Ann Med. 2000;32:293-304.
2. Lerman A, Zeiher AM. Endothelial Function: Cardiac Events. Circulation. 2005;111:363-8.
3. Ružić A.i sur. Endotelna disfunkcija u "enigmatskoj slagalici" kardiovaskularnih bolesti. Med glas. 2009; 6(1): 2-15.
ED
Poredos P. Endothelial dysfunction and cardiovascular disease. Pathophysiol Haemost Thromb. 2002;32:274-7.